Logo image
Back
Sex differences in comorbidities associated with Sjogren's disease
Journal article   Open access   Peer reviewed

Sex differences in comorbidities associated with Sjogren's disease

Katelyn A. Bruno, Andrea Carolina Morales-Lara, Edsel B. Bittencourt, Habeeba Siddiqui, Gabriella Bommarito, Jenil Patel, John M. Sousou, Gary R. Salomon, Rinald Paloka, Shelby T. Watford, …
Frontiers in medicine, Vol.9, pp.958670-958670
08/04/2022
DOI: 10.3389/fmed.2022.958670
PMCID: PMC9387724
PMID: 35991633
url
https://doi.org/10.3389/fmed.2022.958670View
Published (Version of record) Open Access

Abstract

BackgroundLittle is known about the association of comorbidities with sex and age at diagnosis in Sjogren's disease. We tested the hypothesis that sex differences occur in comorbidities in patients with Sjogren's disease. MethodsPatients with Sjogren's disease were identified from 11/1974 to 7/2018 in the Mayo Clinic electronic medical record and assessed for 22 comorbidities according to sex and age at diagnosis. ResultsOf the 13,849 patients identified with Sjogren's disease, 11,969 (86%) were women and 1,880 (14%) men, primarily white (88%) with a sex ratio of 6.4:1 women to men. The mean age at diagnosis was 57 years for women and 59.7 years for men, and 5.6% had a diagnosis of fibromyalgia at Sjogren's diagnosis. Men with Sjogren's disease were more likely than women to be a current or past smoker. The average time to diagnosis of comorbidities after diagnosis of Sjogren's disease was 2.6 years. The top comorbidities in patients with Sjogren's disease were fibromyalgia (25%), depression (21.2%) and pain (16.4%). Comorbidities that occurred more often in women were hypermobile syndromes (31:1), CREST (29:1), migraine (23:1), Ehlers-Danlos syndrome (EDS) (22:1), Raynaud's syndrome (15:1), SLE (13:1), systemic sclerosis (SSc) (13:1), and fibromyalgia (12:1). Women with Sjogren's disease were at increased risk of developing hypermobile syndromes (RR 7.27, CI 1.00-52.71, p = 0.05), EDS (RR 4.43, CI 1.08-18.14, p = 0.039), CREST (RR 4.24, CI 1.56-11.50, p = 0.005), migraine (RR 3.67, CI 2.39-5.62, p < 0.001), fibromyalgia (RR 2.26, CI 1.92-2.66, p < 0.001), Raynaud's syndrome (RR 2.29, CI 1.77-2.96, p < 0.001), SLE (RR 2.13, CI 1.64-2.76, p < 0.001), and SSc (RR 2.05 CI 1.44-2.92; p < 0.001). In contrast, men with Sjogren's were at increased risk for developing myocardial infarction (RR 0.44, CI 0.35-0.55, p < 0.001), atherosclerosis/CAD (RR 0.44, CI 0.39-0.49, p < 0.001), cardiomyopathy (RR 0.63, CI 0.46-0.86, p = 0.003), stroke (RR 0.66 CI 0.51-0.85, p = 0.001), and congestive heart failure (RR 0.70, CI 0.57-0.85, p < 0.001). ConclusionsThe top comorbidities in Sjogren's disease were fibromyalgia, depression, and pain. Women with Sjogren's disease had a higher relative risk of developing fibromyalgia, depression, pain, migraine, hypermobile syndrome, EDS and other rheumatic autoimmune diseases. Men with Sjogren's disease had higher risk of developing cardiovascular diseases.
 General & Internal Medicine Life Sciences & Biomedicine Medicine, General & Internal Science & Technology

Details

Metrics

22 Record Views
21 Times Cited - Web of Science
Logo image